$TRHC News
Last published 1y ago
- 1y agoTRHCRittenhouse Ventures Announces the Successful Close of Fund III, Reinforcing its Commitment to Capital-Efficient B2B SaaS, AI and Tech-Enabled Services CompaniesBusiness WireRittenhouse Ventures, a leading venture capital firm with over 15 years of experience backing the country's top early-stage software founders, today announced the successful closing of Fund III. The new fund will build
- 3y agoTRHCTabula Rasa HealthCare Stockholders Approve Acquisition by Nautic PartnersPR NewswireTabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ: TRHC), a leading healthcare company advancing personalized, comprehensive care for...
- 3y agoHTNXGNTRHCMoore Kuehn Encourages NXGN, NEWR, TRHC, and HT Investors to Contact Law FirmPR NewswireNEW YORK, Oct. 11, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following
- 3y agoCEQPNEWRPFSWTRHC+1Moore Kuehn Encourages, CEPQ, PFSW, TRHC, and NEWR Investors to Contact Law FirmPR NewswireNEW YORK, Oct. 3, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following
- 3y agoTRHCTabula Rasa HealthCare Reports Second Quarter 2023 Financial ResultsPR NewswireContinued Strong Organic Revenue Growth of 24% Second Quarter Adjusted EBITDA of $6.3 Million Increased More Than 3x Compared to Second Quarter 2022 MOORESTOWN, N.J., Aug. 7, 2023 /PRNewswire/ -- Tabula Rasa HealthCare,
- 3y agoTRHCTabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex NeedsPR Newswire$10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with First of its Kind Risk
- 3y agoTRHCTabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference CallPR NewswireMOORESTOWN, N.J., July 25, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2023 financial results Tuesday, August 8, 2023 at 8:30
- 3y agoTRHCMountain Empire PACE Signs with TRHC for Expanded ServicesPR NewswireMOORESTOWN, N.J., May 17, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare company advancing personalized, comprehensive care for value-based care organizations, today
- 3y agoTRHCTabula Rasa HealthCare, Inc. (TRHC) Q1 2023 Earnings Call TranscriptEarnings Call Transcripts
- 3y agoTRHCTabula Rasa HealthCare Reports First Quarter 2023 Financial ResultsPR NewswireFirst Quarter Results Show Benefits of Consistent Execution on Financial and Strategic Objectives First Quarter Revenue Growth of 32% Compared to First Quarter 2022 Raises Full Year 2023 Revenue and Adjusted EBITDA
- 3y agoTRHCTabula Rasa HealthCare Schedules First Quarter 2023 Earnings Conference CallPR NewswireMOORESTOWN, N.J., April 26, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first quarter 2023 financial results Tuesday, May 9, 2023 at 8:30 a.m.
- 3y agoTRHCTabula Rasa HealthCare Provides Corporate UpdatesPR NewswireAppoints Brian Adams as President and Chief Executive Officer and a Member of the Board of Directors, Effective Immediately Appoints Richard W. Rew II as Chief Legal Officer and Corporate Secretary Announces Preliminary
- 3y agoALLTONTFTRHCDSPGON24 Expands Capital Return Program to $125 Million and Announces Governance EnhancementsBusiness WireIncremental $25 Million of Capital to be Returned as Special Cash Dividend Delivering In Aggregate $50 Million Special Cash Dividend Payable in Q2 2023 Cynthia Paul and Ron Mitchell Appointed to Board of Directors;
- 3y agoTRHCTabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial ResultsPR NewswireFourth Quarter Concludes Successful Transformational Year, With Company Sharpening Focus and Laying a Foundation for Sustainable, Profitable Growth Recently Completed Sales of SinfoníaRx and DoseMe Shares Full Year 2023
- 3y agoTRHCMedication Management Services Leader Cureatr Acquires SinfoníaRxPR NewswireNEW YORK, March 3, 2023 /PRNewswire/ -- Cureatr, a national, value-based medication management services company improving quality and reducing total cost of care, announces it has acquired the SinfoníaRx business, an
- 3y agoTRHCTabula Rasa HealthCare Completes the Sale of SinfoníaRx and DoseMeRxPR NewswireMOORESTOWN, N.J., March 2, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that it completed the sale
- 3y agoTRHCTabula Rasa HealthCare Schedules Fourth Quarter and Full Year 2022 Earnings Conference CallPR NewswireMOORESTOWN, N.J., Feb. 21, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2022 financial results Tuesday, March 7,
- 3y agoTRHCNewsweek Names Tabula Rasa HealthCare Among America's Greatest Workplaces for DiversityPR NewswireMOORESTOWN, N.J., Jan. 19, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, was named among America's
- 3y agoTRHCTabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing OperationsPR NewswireReports Preliminary Estimated Revenue from Continuing Operations of $82.0 - $83.0 Million for the Fourth Quarter of 2022, Continuing Strong 2022 Revenue Performance as Company Focuses on Core Business MOORESTOWN, N.J.,
- 4y agoTRHCCenter for Elders' Independence Signs with TRHC for Key PACE ServicesPR NewswireAgreement with one of the nation's largest PACE programs underscores TRHC's momentum delivering PACE-specific products and services into this crucial market MOORESTOWN, N.J., Nov. 8, 2022 /PRNewswire/ -- Tabula
- 4y agoTRHCTabula Rasa HealthCare Reports Third Quarter 2022 ResultsPR NewswireRevenue from continuing operations of $77.1 million increased 14% vs. a year agoGAAP net loss from continuing operations of $25.9 million vs. $11.8 million a year agoAdjusted EBITDA from continuing operations of $2.1
- 4y agoTRHCTabula Rasa HealthCare Names April Gill Chief Commercial OfficerPR NewswireMOORESTOWN, N.J., Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of
- 4y agoTRHCTabula Rasa HealthCare Named a 2022 Champion of Board DiversityPR NewswireMOORESTOWN, N.J., Oct. 26, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, was named a Champion of Board
- 4y agoTRHCTabula Rasa HealthCare Schedules Third Quarter 2022 Earnings Conference CallPR NewswireMOORESTOWN, N.J., Oct. 20, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC), will hold a conference call and webcast to discuss its third quarter 2022 operating results Friday, November 4, 2022 at
- 4y agoTRHCTRHC Adds Ron Mitchell to its Board of DirectorsPR NewswireRon Mitchell, Co-Founder and CEO of Humanity Health, joins Board of Directors MOORESTOWN, N.J., Oct. 11, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology
- 4y agoTRHCTRHC's Clinical Advisory Panel Meeting Provides Insights on PACE PharmacyPR NewswireMOORESTOWN, N.J., Sept. 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, hosted its 2022 CareKinesis Clinical Advisory Panel (CAP) Meeting Septem
- 4y agoTRHCTabula Rasa HealthCare Announces Leadership TransitionPR NewswireDrs. Calvin H. Knowlton and Orsula V. Knowlton to retire from the Company Co-President Brian Adams Named Interim CEO Director Michael Purcell Named Independent Board Chairman MOORESTOWN, N.J., Sept. 14, 2022 /PRNewswire/ -- Tabula Rasa HealthCare
- 4y agoTRHCTabula Rasa HealthCare Announces Cooperation Agreement with Indaba Capital Management to Refresh the Company's Leadership and Board of DirectorsPR NewswireAgreement Also Provides for Enhancements to the Company's Corporate Governance, Including a Commitment to Propose a De-Classification of the Board at the 2023 Annual Meeting MOORESTOWN, N.J., Sept. 14, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.
- 4y agoTRHCNew Study Demonstrates Benefit of Advanced Decision Support in Driving Pharmacist Recommendations to Reduce Medication RiskPR NewswireMedication decision support helps identify potentially inappropriate medication MOORESTOWN, N.J., Aug. 16, 2022 /PRNewswire/ -- A new peer-reviewed study from Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology compan
- 4y agoTRHCIndaba Issues Letter to Tabula Rasa's Independent Directors Regarding Their Apparent Prioritization of the Knowltons' Interests Over Shareholders' InterestsBusiness WireQuestions Why the "Independent" Directors Decided to Dilute Shareholders by Issuing More Equity to the Family-Run Management Team in the Face of the Company's Share Price Dropping 65% Year-to-Date Demands Prompt Answers from Samira K. Beckwith, Jan B
- 4y agoTRHCTabula Rasa HealthCare Reports Second Quarter 2022 ResultsPR NewswireRevenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%. GAAP net loss from continuing operations of $12.7 million vs. $14.1 million a year ago and $20.4 million in Q1 202
- 4y agoTRHCTransaction Data Systems Completes Acquisition of PrescribeWellnessBusiness WireCompany Expands Reach and Patient Access in the Pharmacy Market Transaction Data Systems (TDS), the leader in pharmacy software solutions, today announced the successful completion of its acquisition of PrescribeWellness from Tabula Rasa HealthCare,
- 4y agoTRHCTabula Rasa HealthCare Completes Sale of PrescribeWellness to Transaction Data Systems for $140 MillionPR NewswireMOORESTOWN, N.J., Aug. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® ("TRHC" or the "Company") (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it completed the previously announ
- 4y agoTRHCIndaba Capital Delivers Demand for Inspection of Books and Records of Tabula Rasa HealthCare, Pursuant to Section 220 of Delaware LawBusiness WireSeeks Information to Investigate Potential Misconduct and Assess Each Director's Independence, Adherence to Internal Policies and Performance of Fiduciary Duties Highlights the Board's Seemingly Conflicted Decisions, Including Allowing the Knowlton
- 4y agoTRHCTabula Rasa HealthCare Announces Five-Year Contract Extension with Trinity Health PACEPR NewswireMOORESTOWN, N.J., July 27, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five-year contract renewal with Trinity Health PACE for
- 4y agoTRHCTabula Rasa HealthCare Adopts Limited-Duration Stockholder Rights PlanPR NewswireResponds to Substantial Stock Accumulation by Indaba Capital Management Protects Long-Term Value of All Stockholders' Investments in Tabula Rasa MOORESTOWN, N.J., July 26, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("Tabula Rasa," "TRHC" or th
- 4y agoTRHCTabula Rasa HealthCare Schedules Second Quarter 2022 Earnings Conference CallPR NewswireMOORESTOWN, N.J., July 25, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2022 operating results Friday, August 5, 2022 at 8:30 a.m. EDT. The Company's financia
- 4y agoTRHCTabula Rasa HealthCare Announces Preliminary Second Quarter 2022 Financial ResultsPR NewswireReports Preliminary Revenue from Continuing Operations of $72 to $73 Million for the Second Quarter of 2022, Exceeding Prior Guidance Range and Continuing Strong 2022 Performance as Company Focuses on Core Business Company Comments on Public Statements
- 4y agoTRHCIndaba Capital Issues Letter to Tabula Rasa's Independent Directors Regarding the Urgent Need for Management Changes and a Board RefreshBusiness WireBelieves Board Must Dismantle Husband-and-Wife Management Team That has Presided Over Glaring Conflicts of Interest and Sustained Value Destruction Since Company's 2016 IPO Calls on Board to Demand Resignations of CEO and Chairman Calvin H. Knowlton,
- 4y agoTRHCTabula Rasa HealthCare Agrees to Sell its PrescribeWellness Business to Transaction Data SystemsPR NewswireThe Companies also Agree to a Strategic Multi-Year Partnership MOORESTOWN, N.J., June 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, announce
- 4y agoTRHC4th Annual CareVention HealthCare Summit Attracts Record InterestPR NewswireNearly 40 PACE executives expected to attend this year's conference more than doubling 2021 Summit attendance MOORESTOWN, N.J., June 7, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company a
- 4y agoTRHCTabula Rasa HealthCare Reports First Quarter 2022 ResultsPR NewswireFirst quarter 2022 revenue of $67.1 million from continuing operations includes CareVention HealthCare revenue of $66.3 million, up 19% vs. a year ago Planned sales of PrescribeWellness, SinfoníaRx, and DoseMe expected to add significant liquidity, re
- 4y agoTRHCPharmacist-led Interventions to Improve Medication Use - NCT05346770ClinicalTrials.govMedication safety reviews of patient drug regimen characteristics will be conducted to determine potential drug-drug interactions.
- 4y agoTRHCTabula Rasa HealthCare Schedules First Quarter 2022 Earnings Conference CallPR NewswireMOORESTOWN, N.J., April 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first quarter 2022 operating results Friday, May 6, 2022 at 8:30 a.m. EDT. The conference call will be h
- 4y agoTRHCTabula Rasa HealthCare Announces Partnership Extension with Gary and Mary West PACEPR NewswireTRHC will continue to provide the North County San Diego PACE program with medication safety, pharmacy, and pharmacy benefit solutions MOORESTOWN, N.J., March 29, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healt
- 4y agoTRHCNew Study Further Validates Cost Savings from Unique Medication Risk Mitigation TechnologyPR NewswirePACE participants who received their medication through CareKinesis® had significantly reduced annual medical expenses related to unintended multi-drug interactions compared to other pharmacies MOORESTOWN, N.J., March 17, 2022 /PRNewswire/ -- Techno
- 4y agoTRHCTabula Rasa HealthCare Reports Fourth Quarter and Full Year 2021 ResultsPR NewswireMOORESTOWN, N.J., Feb. 24, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ende
- 4y agoSPGITRHCZBHZimVie to Join S&P SmallCap 600PR NewswireNEW YORK, Feb. 23, 2022 /PRNewswire/ -- ZimVie Inc. (NASD:ZIMV) will replace Tabula Rasa Healthcare Inc. (NASD:TRHC) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, March 2. S&P 500 constituent Zimmer Biomet Holdings Inc.
- 4y agoTRHCTabula Rasa HealthCare Schedules Fourth Quarter 2021 Earnings Conference CallPR NewswireMOORESTOWN, N.J., Feb. 10, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2021 operating results Friday, February 25, 2022 at 8:30 a.m. EDT. The con
- 4y agoTRHCTabula Rasa Healthcare to Sell DoseMeRxPR NewswireMOORESTOWN, N.J., Feb. 9, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ:TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it has signed a non-binding Letter of Intent to sel